annual meeting program - American Society of Clinical Oncology

Defining Professionalism in Oncology: Current Dilemmas and the Future of the
Workforce
Location: E353
CME credit: 1.25
Track(s): Professional Development; Ethics
Timothy Jerome Moynihan, MD—Chair
Mayo Clinic
Can We Teach Professionalism?
Robert Martensen, MD, PhD
National Institutes of Health
Medical Professionalism in Historical Perspective
David H. Johnson, MD
Vanderbilt Ingram Cancer Center
Professionalism and the Oncologist: How Professionalism Impacts Practice
Exploiting the Endocrine Axis in Prostate Cancer Therapy: Current Status and
Future Directions
Location: E Hall D2
CME credit: 1.25
Track(s): Genitourinary Cancer; Geriatric Oncology; Patient and Survivor Care
William K. Oh, MD—Chair
Mount Sinai School of Medicine
Exploiting the Endocrine Axis in Prostate Cancer: What Are the New Targets?
Mary-Ellen Taplin, MD
Dana-Farber Cancer Institute
Recent Advances in Endocrine Therapy for Prostate Cancer: New Agents, New Options
Peter Nelson, MD
Fred Hutchinson Cancer Research Center
Where Is Endocrine Therapy Going in the Next Five Years?
Monday, June 7, 2010
Immunoconjugates as Cancer Therapeutics
Location: S100b
CME credit: 1.25
Track(s): Developmental Therapeutics; Lymphoma and Plasma Cell Disorders; Tumor Biology
Andrew Antony Raubitschek, MD—Chair
City of Hope
The History and Evolution of Immunoconjugate Treatment as Anticancer Therapy
Raffit Hassan, MD
National Cancer Institute
The Present State of Trials Using Immunoconjugates Targeting Solid Tumors and New
Strategies Emerging from the Lab
Paul A. Hamlin, MD
Memorial Sloan-Kettering Cancer Center
The Present State of Trials Using Immunoconjugates Targeting Lymphoma and Heme
Malignancies and New Strategies Emerging from the Lab
389
MONDAY